Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Tiseo

Showing results (1-10 of 362) with videos related to

Pageof 37
Sort By:
Chinese Clinical Oncology|December 12, 2018
Digging into lorlatinib resistance in ALK-positive lung cancer: an editorialFrancesco Facchinetti, Marcello Tiseo
JAMA|April 8, 2004
Predictors of clinical response of non-small cell cancer to gefitinibAndrea Ardizzoni, Marcello Tiseo
Critical Reviews in Oncology/Hematology|May 16, 2006
Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC)Francesco Grossi, Marcello Tiseo
Translational Lung Cancer Research|May 22, 2018
No room for statins in the quest for survival benefits in small cell lung cancerFrancesco Facchinetti, Marcello Tiseo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Current status of second-line treatment and novel therapies for small cell lung cancerMarcello Tiseo, Andrea Ardizzoni
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2007
Combination of target agents: challenges and opportunitiesAndrea Ardizzoni, Marcello Tiseo
Future Oncology (London, England)|August 14, 2015
How to develop novel treatments for EGFR-mutant lung cancerGiuseppe Luigi Banna, Marcello Tiseo
Journal of Thoracic Disease|June 1, 2018
Is the door open to further investigation with antiangiogenesis in SCLC?Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Translational Lung Cancer Research|January 24, 2022
Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorialFrancesco Facchinetti, Marcello Tiseo, Luca Bertolaccini
European Journal of Cancer (Oxford, England : 1990)|July 2, 2014
Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trialsAndrea Ardizzoni, Marcello Tiseo, Luca Boni
Pageof 37

Showing results (1-10 of 362) with videos related to

Sort By:
Pageof 37
Chinese Clinical Oncology|December 12, 2018
Digging into lorlatinib resistance in ALK-positive lung cancer: an editorialFrancesco Facchinetti, Marcello Tiseo
JAMA|April 8, 2004
Predictors of clinical response of non-small cell cancer to gefitinibAndrea Ardizzoni, Marcello Tiseo
Critical Reviews in Oncology/Hematology|May 16, 2006
Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC)Francesco Grossi, Marcello Tiseo
Translational Lung Cancer Research|May 22, 2018
No room for statins in the quest for survival benefits in small cell lung cancerFrancesco Facchinetti, Marcello Tiseo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Current status of second-line treatment and novel therapies for small cell lung cancerMarcello Tiseo, Andrea Ardizzoni
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2007
Combination of target agents: challenges and opportunitiesAndrea Ardizzoni, Marcello Tiseo
Future Oncology (London, England)|August 14, 2015
How to develop novel treatments for EGFR-mutant lung cancerGiuseppe Luigi Banna, Marcello Tiseo
Journal of Thoracic Disease|June 1, 2018
Is the door open to further investigation with antiangiogenesis in SCLC?Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Translational Lung Cancer Research|January 24, 2022
Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorialFrancesco Facchinetti, Marcello Tiseo, Luca Bertolaccini
European Journal of Cancer (Oxford, England : 1990)|July 2, 2014
Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trialsAndrea Ardizzoni, Marcello Tiseo, Luca Boni
Pageof 37